肝病患者-话题@MedSci

#肝病患者#

84篇内容 | 2223人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2017947, encodeId=8a52201e947c6, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Eur J Gastroenterol Hepatol：HA和M30，联合或单独使用，可能能够预测非酒精性肝病患者的显著肝纤维化, objectType=article, longId=139435, objectId=7e51139435a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e51139435a3, replyNumber=0, likeNumber=61, createdTime=2019-02-09, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e51139435a3, moduleTitle=Eur J Gastroenterol Hepatol：HA和M30，联合或单独使用，可能能够预测非酒精性肝病患者的显著肝纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e51139435a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017935, encodeId=99e7201e935b5, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Gastroenterology：增强型肝纤维化测试、Fibrotest、弹性成像、间接肝纤维化指标等评估酒精性肝病患者进展性肝纤维化的效能, objectType=article, longId=126817, objectId=ad1a12681e0a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad1a12681e0a, replyNumber=0, likeNumber=74, createdTime=2018-11-27, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad1a12681e0a, moduleTitle=Gastroenterology：增强型肝纤维化测试、Fibrotest、弹性成像、间接肝纤维化指标等评估酒精性肝病患者进展性肝纤维化的效能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad1a12681e0a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017924, encodeId=bf1a201e92465, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Aliment Pharmacol Ther：改善晚期肝病患者的生活质量不妨这样做, objectType=article, longId=107042, objectId=e89410e0425e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e89410e0425e, replyNumber=0, likeNumber=49, createdTime=2018-06-09, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e89410e0425e, moduleTitle=Aliment Pharmacol Ther：改善晚期肝病患者的生活质量不妨这样做, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e89410e0425e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017927, encodeId=11f1201e92737, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Hepatology：肥胖、胰岛素抵抗等因素对非酒精性脂肪肝病患者血浆氨基酸含量的影响, objectType=article, longId=110598, objectId=893711059881, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=893711059881, replyNumber=0, likeNumber=56, createdTime=2017-11-18, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=893711059881, moduleTitle=Hepatology：肥胖、胰岛素抵抗等因素对非酒精性脂肪肝病患者血浆氨基酸含量的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=893711059881)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017944, encodeId=5f72201e9445e, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Liver Int：糖尿病影响非侵入性肝纤维化模型预测非酒精性脂肪性肝病患者肝硬化和预后的预测, objectType=article, longId=135308, objectId=e97213530827, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e97213530827, replyNumber=0, likeNumber=64, createdTime=2018-07-13, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e97213530827, moduleTitle=Liver Int：糖尿病影响非侵入性肝纤维化模型预测非酒精性脂肪性肝病患者肝硬化和预后的预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e97213530827)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017926, encodeId=7027201e92647, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=慢性肝病患者肝脏和骨髓之间存在免疫对话, objectType=article, longId=109077, objectId=7cf51090e7a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cf51090e7a9, replyNumber=0, likeNumber=65, createdTime=2018-03-08, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cf51090e7a9, moduleTitle=慢性肝病患者肝脏和骨髓之间存在免疫对话, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cf51090e7a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017942, encodeId=4418201e94252, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Hepatol Res：胰岛素耐受增加了非酒精性肝病患者2型糖尿病患病风险, objectType=article, longId=135012, objectId=506d1350128e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=506d1350128e, replyNumber=0, likeNumber=66, createdTime=2018-12-22, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=506d1350128e, moduleTitle=Hepatol Res：胰岛素耐受增加了非酒精性肝病患者2型糖尿病患病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=506d1350128e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017932, encodeId=f727201e93284, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Aliment Pharm Therap：肝病患者服用β受体阻滞剂哪项心肺运动测试不受影响？, objectType=article, longId=116836, objectId=5f23116836cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f23116836cc, replyNumber=0, likeNumber=65, createdTime=2018-01-31, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f23116836cc, moduleTitle=Aliment Pharm Therap：肝病患者服用β受体阻滞剂哪项心肺运动测试不受影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f23116836cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017938, encodeId=a13c201e93877, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Dig Liver Dis：非肥胖的非酒精性脂肪性肝病患者患糖尿病的风险增加, objectType=article, longId=129126, objectId=d595129126db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d595129126db, replyNumber=0, likeNumber=97, createdTime=2018-12-18, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d595129126db, moduleTitle=Dig Liver Dis：非肥胖的非酒精性脂肪性肝病患者患糖尿病的风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d595129126db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017940, encodeId=56c2201e94092, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=SCI REP：丙型肝炎病毒感染对老年慢性肝病患者胆石病发病率的影响！, objectType=article, longId=132594, objectId=e263132594e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e263132594e3, replyNumber=0, likeNumber=78, createdTime=2018-06-16, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e263132594e3, moduleTitle=SCI REP：丙型肝炎病毒感染对老年慢性肝病患者胆石病发病率的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e263132594e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017931, encodeId=e55e201e931cb, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Nat Commun：肝病患者的救星，科学家发现肝脏疾病的治疗关键, objectType=article, longId=116491, objectId=f9bc1164912c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9bc1164912c, replyNumber=0, likeNumber=65, createdTime=2017-12-02, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9bc1164912c, moduleTitle=Nat Commun：肝病患者的救星，科学家发现肝脏疾病的治疗关键, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9bc1164912c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017930, encodeId=f05c201e930ac, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=J Hepatol：非酒精性脂肪性肝病患者发生慢性肾脏疾病风险, objectType=article, longId=112334, objectId=cf7d112334db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf7d112334db, replyNumber=0, likeNumber=71, createdTime=2018-01-10, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf7d112334db, moduleTitle=J Hepatol：非酒精性脂肪性肝病患者发生慢性肾脏疾病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf7d112334db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017929, encodeId=bf9a201e929c0, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Gut：关乎上亿肝病患者，中国研究人员参与发现阻断肝硬化新机制，填补领域空白！, objectType=article, longId=110941, objectId=46a2110941ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46a2110941ca, replyNumber=0, likeNumber=74, createdTime=2018-07-27, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46a2110941ca, moduleTitle=Gut：关乎上亿肝病患者，中国研究人员参与发现阻断肝硬化新机制，填补领域空白！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46a2110941ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017918, encodeId=2f0a201e918e4, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=JAHA：终末期肝病患者多巴酚丁胺负荷灌注超声心动图的预测价值何如？, objectType=article, longId=89552, objectId=a26b8955251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a26b8955251, replyNumber=0, likeNumber=72, createdTime=2017-05-19, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a26b8955251, moduleTitle=JAHA：终末期肝病患者多巴酚丁胺负荷灌注超声心动图的预测价值何如？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a26b8955251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017919, encodeId=7b31201e9193b, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Clin Gastroenterol H：慢性肝病患者服用他汀类药物与肝硬化及相关并发症的风险分析！, objectType=article, longId=98226, objectId=763698226fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=763698226fc, replyNumber=0, likeNumber=70, createdTime=2017-06-19, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=763698226fc, moduleTitle=Clin Gastroenterol H：慢性肝病患者服用他汀类药物与肝硬化及相关并发症的风险分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=763698226fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017923, encodeId=9d20201e923b5, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Hepatology：非酒精性脂肪性肝病患者适度饮酒是好是坏？, objectType=article, longId=104178, objectId=1b741041e8ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b741041e8ee, replyNumber=0, likeNumber=102, createdTime=2018-01-09, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b741041e8ee, moduleTitle=Hepatology：非酒精性脂肪性肝病患者适度饮酒是好是坏？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b741041e8ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017928, encodeId=7dca201e9280e, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Hepatol：晚期肝病患者接受直接抗病毒药物治疗获得持续病毒学应答后对死亡率的影响, objectType=article, longId=110601, objectId=5ce811060188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ce811060188, replyNumber=0, likeNumber=58, createdTime=2018-02-27, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ce811060188, moduleTitle=Hepatol：晚期肝病患者接受直接抗病毒药物治疗获得持续病毒学应答后对死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ce811060188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017921, encodeId=1b17201e9219d, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=肝病患者在夏季如何护理, objectType=article, longId=101747, objectId=903c101e478a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=903c101e478a, replyNumber=0, likeNumber=61, createdTime=2017-07-02, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=903c101e478a, moduleTitle=肝病患者在夏季如何护理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=903c101e478a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017925, encodeId=f1a5201e925ef, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=慢性肝病患者肠外肠内营养支持与膳食干预专家共识, objectType=article, longId=107137, objectId=cba710e13705, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cba710e13705, replyNumber=0, likeNumber=34, createdTime=2017-10-06, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cba710e13705, moduleTitle=慢性肝病患者肠外肠内营养支持与膳食干预专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cba710e13705)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2017922, encodeId=342c201e922b4, content=<a href='/topic/show?id=41ab81258fb' target=_blank style='color:#2F92EE;'>#肝病患者#</a>, objectTitle=Metabolism：非酒精性脂肪性肝病患者载脂蛋白B脂代谢异常血症患病率高！, objectType=article, longId=103307, objectId=c10310330eba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c10310330eba, replyNumber=0, likeNumber=67, createdTime=2018-05-24, rootId=0, userName=chenzhuanggui, userId=8949377, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c10310330eba, moduleTitle=Metabolism：非酒精性脂肪性肝病患者载脂蛋白B脂代谢异常血症患病率高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c10310330eba)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肝病患者

2020-05-29

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Eur J Gastroenterol Hepatol：HA和M30，联合或单独使用，可能能够预测非酒精性肝病患者的显著肝纤维化

2019-02-09

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Gastroenterology：增强型肝纤维化测试、Fibrotest、弹性成像、间接肝纤维化指标等评估酒精性肝病患者进展性肝纤维化的效能

2018-11-27

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Aliment Pharmacol Ther：改善晚期肝病患者的生活质量不妨这样做

2018-06-09

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Hepatology：肥胖、胰岛素抵抗等因素对非酒精性脂肪肝病患者血浆氨基酸含量的影响

2017-11-18

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Liver Int：糖尿病影响非侵入性肝纤维化模型预测非酒精性脂肪性肝病患者肝硬化和预后的预测

2018-07-13

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

慢性肝病患者肝脏和骨髓之间存在免疫对话

2018-03-08

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Hepatol Res：胰岛素耐受增加了非酒精性肝病患者2型糖尿病患病风险

2018-12-22

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Aliment Pharm Therap：肝病患者服用β受体阻滞剂哪项心肺运动测试不受影响？

2018-01-31

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Dig Liver Dis：非肥胖的非酒精性脂肪性肝病患者患糖尿病的风险增加

2018-12-18

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

SCI REP：丙型肝炎病毒感染对老年慢性肝病患者胆石病发病率的影响！

2018-06-16

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Nat Commun：肝病患者的救星，科学家发现肝脏疾病的治疗关键

2017-12-02

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

J Hepatol：非酒精性脂肪性肝病患者发生慢性肾脏疾病风险

2018-01-10

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Gut：关乎上亿肝病患者，中国研究人员参与发现阻断肝硬化新机制，填补领域空白！

2018-07-27

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

JAHA：终末期肝病患者多巴酚丁胺负荷灌注超声心动图的预测价值何如？

2017-05-19

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Clin Gastroenterol H：慢性肝病患者服用他汀类药物与肝硬化及相关并发症的风险分析！

2017-06-19

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Hepatology：非酒精性脂肪性肝病患者适度饮酒是好是坏？

2018-01-09

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Hepatol：晚期肝病患者接受直接抗病毒药物治疗获得持续病毒学应答后对死亡率的影响

2018-02-27

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

肝病患者在夏季如何护理

2017-07-02

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

慢性肝病患者肠外肠内营养支持与膳食干预专家共识

2017-10-06

chenzhuanggui (审核中...)

前往app查看评论内容

#肝病患者#

Metabolism：非酒精性脂肪性肝病患者载脂蛋白B脂代谢异常血症患病率高！

2018-05-24

科室
- - 订阅+
  - 更多科室
工具
服务